BCAB

Bioatla Inc (BCAB)

US
$ 0.67810.42%

Price Chart

Key Statistics

Market Cap
$ 23.08M
P/E Ratio
0.00
Revenue (TTM)
$ 11M
Volume
2.4M
52W High
$ 2.52
52W Low
$ 0.24
Dividend Yield
0.00%
Beta
0.91

Technicals

50-Day MA
0.4231
200-Day MA
0.9384
52 Week High
2.525
52 Week Low
0.24

About BCAB

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

Employees
61
Headquarters
San Diego, CA
CEO
Dr. Jay M. Short Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
QS
QuantumScape Corpor...
$ 5.64
30.56
UAVS
AgEagle Aerial Syst...
$ 1.12
5.66
DKS
Dick's Sporting Goo...
$ 185.06
3.81
KMT
Kennametal Inc. Com...
$ 22.73
3.18
ICL
ICL Group Ltd. Ordi...
$ 6.83
2.71

Top Losers

Symbol/Name
LTP
% Chg
WGO
Winnebago Industrie...
$ 28.87
-7.73
OKLO
Oklo Inc.
$ 56.60
-6.77
PRI
Primerica Inc. Comm...
$ 250.54
-6.62
ACHR
Archer Aviation Inc...
$ 10.05
-6.34
BXP
Boston Properties I...
$ 66.90
-4.90